Skip Nav

Clinical Guidelines Portal

Home > Guidelines > Perinatal Guidelines > Appendix A: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Text Size

Updated Perinatal Guideline

Updates were made to the Perinatal Guideline on January 22, 2013 and January 29, 2012. For an explanation of the updates, please see the correction notice.

Search Search Help

Guideline Search

Type your search term(s) in the text box. Users can only search one guideline at a time. To search for an exact phrase, use quotation marks (i.e. "what to start"). To narrow your search, add additional relevant terms. If you are not finding what you need, try searching similar terms (i.e. perinatal OR pregnancy) to broaden your search.Close

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Appendix A: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy

Printer-Friendly Files

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors 

Protease Inhibitors 

Entry Inhibitors 

Integrase Inhibitors 

Antiretroviral Pregnancy Registry